Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

5090 ARTíCULOS , VIENDO DEL 5011 AL 5025

PUBMED

Identification of NUB1 as a suppressor of mutant Huntington toxicity via enhanced protein clearance.

Lu B, Al-Ramahi I, Valencia A, Wang Q, Berenshteyn F, Yang H, Gallego-Flores T, Ichcho S, Lacoste A, Hild M, Difiglia M, Botas J, Palacino J.

Nat Neurosci. 2013 May;16(5):562-70. doi: 10.1038/nn.3367.

0

0

0

PUBMED

Discrete changes in the frequency and functions of autobiographical reminiscence in Huntington's disease.

Carmichael AM, Irish M, Glikmann-Johnston Y, Stout JC.

Memory. 2019 Nov;27(10):1345-1351. doi: 10.1080/09658211.2019.1654519. Epub 2019 Aug 19.

0

0

0

PUBMED

DNA repair mechanisms in Huntington's disease.

Jonson I, Ougland R, Larsen E.

Mol Neurobiol. 2013 Jun;47(3):1093-102. doi: 10.1007/s12035-013-8409-7. Review.

0

0

0

PUBMED

Profiles of motor and cognitive impairment in the transgenic rat model of Huntington's disease.

Fielding SA, Brooks SP, Klein A, Bayram-Weston Z, Jones L, Dunnett SB.

Brain Res Bull. 2012 Jun 1;88(2-3):223-36. doi: 10.1016/j.brainresbull.2011.09.011.

0

0

0

PUBMED

Age at onset in Huntington's disease: replication study on the associations of ADORA2A, HAP1 and OGG1.

Taherzadeh-Fard E, Saft C, Wieczorek S, Epplen JT, Arning L.

Neurogenetics. 2010 Oct;11(4):435-9. doi: 10.1007/s10048-010-0248-3.

0

0

0

PUBMED

Sex Differences in Circadian Dysfunction in the BACHD Mouse Model of Huntington's Disease.

Kuljis DA, Gad L, Loh DH, MacDowell Kaswan Z, Hitchcock ON, Ghiani CA, Colwell CS.

PLoS One. 2016 Feb 12;11(2):e0147583. doi: 10.1371/journal.pone.0147583.

0

0

0

PUBMED

High-content chemical and RNAi screens for suppressors of neurotoxicity in a Huntington's disease model.

Schulte J, Sepp KJ, Wu C, Hong P, Littleton JT.

PLoS One. 2011;6(8):e23841. doi: 10.1371/journal.pone.0023841.

0

0

0

PUBMED

Gene Therapy for Huntington's Disease Using Targeted Endonucleases.

Dabrowska M, Olejniczak M.

Methods Mol Biol. 2020;2056:269-284. doi: 10.1007/978-1-4939-9784-8_17.

0

0

0

PUBMED

FAN1 modifies Huntington's disease progression by stabilising the expanded HTT CAG repeat.

Goold R, Flower M, Moss DH, Medway C, Wood-Kaczmar A, Andre R, Farshim P, Bates GP, Holmans P, Jones L, Tabrizi SJ.

Hum Mol Genet. 2018 Oct 24. doi: 10.1093/hmg/ddy375. [Epub ahead of print]

0

0

0

PUBMED

Metoprolol-pridopidine drug-drug interaction and food effect assessments of pridopidine, a new drug for treatment of Huntington Disease.

Rabinovich-Guilatt L, Steiner L, Hallak H, Pastino G, Muglia P, Spiegelstein O.

Br J Clin Pharmacol. 2017 Apr 27. doi: 10.1111/bcp.13317. [Epub ahead of print]

0

0

0

PUBMED

Functional and connectivity changes during working memory in Huntington's disease: 18 month longitudinal data from the IMAGE-HD study.

Georgiou-Karistianis N, Poudel GR, Domínguez D JF, Langmaid R, Gray MA, Churchyard A, Chua P, Borowsky B, Egan GF, Stout JC.

Brain Cogn. 2013 Oct;83(1):80-91. doi: 10.1016/j.bandc.2013.07.004.

0

0

0

PUBMED

A broad phenotypic screen identifies novel phenotypes driven by a single mutant allele in Huntington's disease CAG knock-in mice.

Hölter SM, Stromberg M, Kovalenko M, Garrett L, Glasl L, Lopez E, Guide J, Götz A, Hans W, Becker L, Rathkolb B, Rozman J, Schrewed A, Klingenspor M, Klopstock T, Schulz H, Wolf E, Wursta W, Gillis T,

PLoS One. 2013 Nov 22;8(11):e80923. doi: 10.1371/journal.pone.0080923.

0

0

0

PUBMED

Surface electromyograph activity of submental muscles during swallowing and expiratory muscle training tasks in Huntington's disease patients.

Reyes A, Cruickshank T, Thompson J, Ziman M, Nosaka K.

J Electromyogr Kinesiol. 2014 Feb;24(1):153-8. doi: 10.1016/j.jelekin.2013.09.009.

0

0

0

PUBMED

Natural variation in sensory-motor white matter organization influences manifestations of Huntington's disease.

Orth M, Gregory S, Scahill RI, Mayer IS, Minkova L, Klöppel S, Seunarine KK, Boyd L, Borowsky B, Reilmann R, Bernhard Landwehrmeyer G, Leavitt BR, Roos RA, Durr A, Rees G, Rothwell JC, Langbehn D, Tab

Hum Brain Mapp. 2016 Dec;37(12):4615-4628. doi: 10.1002/hbm.23332.

0

0

0

PUBMED

Characterization of forebrain neurons derived from late-onset Huntington's disease human embryonic stem cell lines.

Niclis JC, Pinar A, Haynes JM, Alsanie W, Jenny R, Dottori M, Cram DS.

Front Cell Neurosci. 2013 Apr 5;7:37. doi: 10.3389/fncel.2013.00037.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy